We just received data on a new analyst forecast for $CVS. Lance Wilkes from Bernstein set a price target of 86.0 for CVS.
To track analyst ratings and price targets for $CVS, check out Quiver Quantitative's $CVS forecast page.
Should you buy $CVS?
Some analysts are better than others. To view the past performance of Bernstein, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CVS Price Targets
Multiple analysts have issued price targets for $CVS recently. We have seen 14 analysts offer price targets for $CVS in the last 6 months, with a median target of $92.0.
Here are some recent targets:
- Lance Wilkes from Bernstein set a target price of $86.0 on 12/05/2025
- Stephen Baxter from Wells Fargo set a target price of $102.0 on 11/13/2025
- Charles Rhyee from TD Cowen set a target price of $100.0 on 11/03/2025
- Sarah James from Cantor Fitzgerald set a target price of $95.0 on 10/30/2025
- David Macdonald from Truist Securities set a target price of $95.0 on 10/30/2025
- Ben Hendrix from RBC Capital set a target price of $93.0 on 10/30/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $95.0 on 10/30/2025
$CVS Insider Trading Activity
$CVS insiders have traded $CVS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CVS stock by insiders over the last 6 months:
- ANNE A. FINUCANE sold 7,500 shares for an estimated $532,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CVS Revenue
$CVS had revenues of $102.9B in Q3 2025. This is an increase of 7.8% from the same period in the prior year.
You can track CVS financials on Quiver Quantitative's CVS stock page.
$CVS Congressional Stock Trading
Members of Congress have traded $CVS stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CVS stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CVS Hedge Fund Activity
We have seen 872 institutional investors add shares of $CVS stock to their portfolio, and 958 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 8,398,255 shares (+31.2%) to their portfolio in Q3 2025, for an estimated $633,144,444
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,472,749 shares (+69.0%) to their portfolio in Q3 2025, for an estimated $487,980,547
- WELLINGTON MANAGEMENT GROUP LLP added 5,042,816 shares (+391.6%) to their portfolio in Q3 2025, for an estimated $380,177,898
- CITADEL ADVISORS LLC removed 4,959,383 shares (-60.7%) from their portfolio in Q3 2025, for an estimated $373,887,884
- AMUNDI added 3,637,943 shares (+95.3%) to their portfolio in Q3 2025, for an estimated $274,264,522
- JENNISON ASSOCIATES LLC removed 3,022,874 shares (-75.3%) from their portfolio in Q3 2025, for an estimated $227,894,470
- BLACKROCK, INC. removed 2,850,536 shares (-2.3%) from their portfolio in Q3 2025, for an estimated $214,901,909
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
